CIPLA.NS
Cipla Limited
NSE
520.404.55 (0.88%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close515.85
Open516.00
Bid520.40 x
Ask0.00 x
52wk Range457.45 - 745.00
Day's Range512.35 - 522.90
Volume1,188,747
Avg Vol (3m)1,665,029
As of 5:59 AM EDT. Market closed.
  • Reuters4 months ago

    Indian court extends relief to pharma firms in drug ban case

    Several companies, including Indian units of Abbott Laboratories and Pfizer Inc , and domestic firms like Cipla Ltd and Macleods Pharmaceuticals, went to the Delhi High Court to try to get the ban lifted. On Monday, judge Rajiv Sahai Endlaw moved the hearing into his chamber from a courtroom packed with lawyers and company executives. Archana Sachdeva, a lawyer representing Cipla among other firms, said he had ordered the next hearing on March 28.

  • Reuters5 months ago

    US and EU regulators urge Indian drug companies to step up standards

    U.S. and EU drug regulators called upon India's pharmaceutical sector on Tuesday to step up efforts to improve manufacturing standards and ensure the reliability of data if it is to maintain its dominance in the generic drugs industry. India's $15 billion pharmaceutical industry, an increasingly important global supplier of cheaper generic medicines, has been dogged by concerns over quality issues after the U.S. Food and Drug Administration banned a series of factories from producing medicines for the United States due to inadequate standards. The European Medicines Agency (EMA), and the UK's Medicines and Health Regulatory Authority (MHRA) also barred some Indian plants from producing drugs for their markets.